Related Experiment Video

Updated: May 20, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

Recurrent/moderate hypoglycemia induces hippocampal dendritic injury, microglial activation, and cognitive impairment

Seok Joon Won1, Byung Hoon Yoo, Tiina M Kauppinen

  • 1Department of Neurology, University of California at San Francisco and Veterans Affairs Medical Center, San Francisco, CA, USA.

Journal of Neuroinflammation
|July 27, 2012
PubMed
Abstract

Insights

Recurrent moderate hypoglycemia in type 1 diabetes causes hippocampal dendritic injury and cognitive impairment. NADPH oxidase inhibition may prevent these effects, particularly in diabetic individuals.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Diabetes Research

Background:

  • Recurrent moderate hypoglycemia is a frequent complication in type 1 diabetes.
  • Chronic hypoglycemia can lead to cognitive impairment.

Purpose of the Study:

  • To investigate if recurrent moderate hypoglycemia causes neuronal death, dendritic injury, or cognitive impairment.
  • To assess the role of oxidative stress and NADPH oxidase in these effects.

Main Methods:

  • Experiments were conducted on normal and diabetic rats subjected to insulin-induced hypoglycemia.
  • Oxidative stress, neuronal death, and cognitive function were evaluated.
  • The NADPH oxidase inhibitor, apocynin, was used to test its protective effects.

Main Results:

  • Recurrent moderate hypoglycemia induced oxidative injury and dendritic thinning in the hippocampus.
  • Significant cognitive impairment was observed 6 weeks post-hypoglycemia.
  • Diabetic rats exhibited more severe oxidative injury and cognitive deficits.
  • Apocynin treatment reduced oxidative damage and microglial activation.

Conclusions:

  • Oxidative injury in the hippocampus following recurrent moderate hypoglycemia is linked to chronic cognitive impairment in diabetes.
  • NADPH oxidase inhibition shows potential in preventing hypoglycemia-induced hippocampal dendritic injury.

More Related Videos

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish05:49

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish

Published on: May 5, 2021

Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing10:32

Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing

Published on: January 11, 2013

Related Concept Videos

Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...